Prophylactic pegfilgrastim significantly reduces febrile neutropenia during moderately myelosuppressive chemotherapy.
Publication
, Journal Article
Price, N; Jain, VK; Lyman, GH
Published in: Support Cancer Ther
July 1, 2004
Duke Scholars
Published In
Support Cancer Ther
DOI
ISSN
1543-2912
Publication Date
July 1, 2004
Volume
1
Issue
4
Start / End Page
207 / 209
Location
United States
Related Subject Headings
- Oncology & Carcinogenesis
Citation
APA
Chicago
ICMJE
MLA
NLM
Price, N., Jain, V. K., & Lyman, G. H. (2004). Prophylactic pegfilgrastim significantly reduces febrile neutropenia during moderately myelosuppressive chemotherapy. Support Cancer Ther, 1(4), 207–209. https://doi.org/10.1016/s1543-2912(13)60128-9
Price, Nancy, Vinay K. Jain, and Gary H. Lyman. “Prophylactic pegfilgrastim significantly reduces febrile neutropenia during moderately myelosuppressive chemotherapy.” Support Cancer Ther 1, no. 4 (July 1, 2004): 207–9. https://doi.org/10.1016/s1543-2912(13)60128-9.
Price N, Jain VK, Lyman GH. Prophylactic pegfilgrastim significantly reduces febrile neutropenia during moderately myelosuppressive chemotherapy. Support Cancer Ther. 2004 Jul 1;1(4):207–9.
Price, Nancy, et al. “Prophylactic pegfilgrastim significantly reduces febrile neutropenia during moderately myelosuppressive chemotherapy.” Support Cancer Ther, vol. 1, no. 4, July 2004, pp. 207–09. Pubmed, doi:10.1016/s1543-2912(13)60128-9.
Price N, Jain VK, Lyman GH. Prophylactic pegfilgrastim significantly reduces febrile neutropenia during moderately myelosuppressive chemotherapy. Support Cancer Ther. 2004 Jul 1;1(4):207–209.
Published In
Support Cancer Ther
DOI
ISSN
1543-2912
Publication Date
July 1, 2004
Volume
1
Issue
4
Start / End Page
207 / 209
Location
United States
Related Subject Headings
- Oncology & Carcinogenesis